Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Interest Expenses (2016 - 2025)

Pediatrix Medical (MD) has disclosed Interest Expenses for 17 consecutive years, with $8.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 9.99% to $8.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.0 million, a 11.73% decrease, with the full-year FY2025 number at $36.0 million, down 11.73% from a year prior.
  • Interest Expenses was $8.7 million for Q4 2025 at Pediatrix Medical, down from $8.9 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $17.6 million in Q1 2021 to a low of $8.4 million in Q2 2022.
  • A 5-year average of $11.4 million and a median of $10.2 million in 2024 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: plummeted 50.18% in 2022, then soared 33.55% in 2023.
  • Pediatrix Medical's Interest Expenses stood at $16.6 million in 2021, then tumbled by 40.06% to $10.0 million in 2022, then increased by 1.3% to $10.1 million in 2023, then decreased by 3.68% to $9.7 million in 2024, then dropped by 9.99% to $8.7 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Interest Expenses are $8.7 million (Q4 2025), $8.9 million (Q3 2025), and $9.1 million (Q2 2025).